Characterisation of liposomes containing aminolevulinic acid and derived esters

Journal of Photochemistry and Photobiology B: Biology

Volumn 92, Issue 1, 2008, Pages 1-9

  Di Venosa, Gabriela ^a   Hermida, Laura ^b   Batlle, Alcira ^a   Fukuda, Haydée ^a   Defain, María Victoria ^b   Mamone, Leandro ^a   Rodriguez, Lorena ^a   MacRobert, Alexander ^c   Casas, Adriana ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA INDUSTRIAL   (Argentina)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

ALA; ALA esters; Aminolevulinic acid; Liposomes; PDT; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID UNDECANOYL ESTER; LIPOSOME; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOTOSENSITIZING AGENT;

ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DILUTION; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; LIPOSOMAL DELIVERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STORAGE TEMPERATURE;

AMINOLEVULINIC ACID; DRUG DELIVERY SYSTEMS; ESTERS; LIPOSOMES; PHOSPHATIDIC ACIDS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PHOTOCHEMOTHERAPY;

EID: 46749103731     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2008.03.008     Document Type: Article

References (33)

1. In: Gomer C.J. (Ed). Photodynamic Therapy (1987), Pergamon Press, Oxford, England
2. Weishaupt K., Gomer C., and Dougherty T. Identification of singlet oxygen as the cytotoxic agent in photoactivation of a murine tumour. Cancer Res. 36 (1976) 2326-2329
3. Kennedy J., Pottier R., and Pross G. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B 6 (1990) 143-148
4. Boehncke W., Sterry W., and Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343 (1994) 801
5. Jenkins M., Buonaccorsi G., MacRobert A., Bishop C., Bown S., and McEwan J. Intra-arterial photodynamic therapy using 5-ALA in a swine model. Eur. J. Vasc. Endovasc. Surg. 16 (1998) 284-291
6. Krzemien A., Van Vugt D., Pottier R., Dickson E., and Reid R. Evaluation of novel nonlaser light source for endometrial ablation using 5-aminolevulinic acid. Lasers Surg. Med. 25 (1999) 315-322
7. Kloek J., and Beijersbergen Van Henegouwen G.M.J. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. 64 (1996) 994-1000
8. Gaullier J.M., Berg K., Peng Q., Anholt H., Selbo P.K., Ma L.W., and Moan J. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 57 (1997) 1481-1486
9. Casas A., and Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr Med. Chem. Anti-Cancer Agents 2 (2002) 465-475
10. Schmidbauer J., Witjes F., Schmeller N., Donat R., Susani M., and Marberger M. Hexvix PCB301/01 Study Group, Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J. Urol. 171 (2004) 135-138
11. Di Venosa G., Batlle A., Fukuda H., MacRobert A., and Casas A. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues. Cancer Chemother. Pharmacol. 58 (2006) 478-486
12. Rodriguez L., Batlle A., Di Venosa G., Battah S., Dobbin P., MacRobert A., and Casas A. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br. J. Pharmacol. 147 (2006) 825-833
13. Pass H. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85 (1993) 443-456
14. Derycke A.S., and Witte P.A. Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 56 (2004) 17-30
15. Konan Y.N., Gurny R., and Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B. 66 (2002) 89-106
16. Reddi E. Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B. 37 (1997) 189-195
17. Fukuda H., Paredes S., and Batlle A.M. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Drug Des. Deliv. 5 (1989) 133-139
18. Casas A., Perotti C., Saccoliti M., Sacca P., Fukuda H., and Batlle A.M. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures. Br. J. Cancer 86 (2002) 837-842
19. Fukuda H., Paredes S., and Batlle A.M. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp. Biochem. Physiol. B. 102 (1992) 433-436
20. Casas A., Fukuda H., Di Venosa G., and Batlle A.M. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Br. J. Dermatol. 143 (2000) 564-572
21. Pierre M.B., Tedesco A.C., Marchetti J.M., and Bentley M.V. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol. 1 (2001) 5
22. Kosobe T., Moriyama E., Tokuoka Y., and Kawashima N. Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells. Drug Dev. Ind. Pharm. 31 (2005) 623-629
23. Han I., Jun M., Kim S., Kim M., and Kim J. Expression and intensity of protoporphyrin IX induced by liposomal 5-aminolevulinic acid in rat pilosebaceous unit throughout hair cycle. Arch. Dermatol. Res. 297 (2005) 210-217
24. Takeya H. Preparation of 5-aminolevulinic acid alkyl esters as herbicides. Chem. Abs. 116 (1992) 189633m
25. Fry D., White C., and Goldman D. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal. Biochem. 90 (1978) 809-815
26. Stewart J. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 10 (1959) 10-14
27. Mauzerall M., and Granick S. The occurrence and determination of 5-aminolevulinic acid and porphobilinogen in urine. J. Biol. Chem. 219 (1956) 435-437
28. Di Venosa G., Fukuda H., Perotti C., Batlle A., and Casas A. A simple method for separating ALA from ALA derivatives using ionic exchange chromatography. J. Photochem. Photobiol. B 75 (2004) 157-163
29. Di Venosa G., Batlle A., Fukuda H., MacRobert A., and Casas A. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues. Cancer Chemother. Pharmacol. 58 (2006) 478-486
30. Jorgensen W.L., and Madura J.D. Temperature and size dependence for Monte Carlo simulations of TIP4P water. Mol. Phys. 56 (1985) 1381-1392
31. Rodriguez L., Batlle A., Di Venosa G., Battah S., Dobbin P., MacRobert A.J., and Casas A. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br. J. Pharmacol. 147 (2006) 825-833
32. Bermudez Moretti M., Correa Garcia S., Perotti C., Batlle A., and Casas A. Delta-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters. Br. J. Cancer 87 (2002) 471-474
33. Rodriguez L., Batlle A., Di Venosa G., MacRobert A.J., Battah S., Daniel H., and Casas A. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours. Int. J. Biochem. Cell Biol. 38 (2006) 1530-1539